DMAAU
NASDAQ
$10.99
Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) (DMAAU)
Drugs Made In America Acquisition Corp. Units (DMAAU) is a special purpose acquisition company (SPAC) focused on merging with innovative firms within the pharmaceutical and healthcare sectors. Leveraging a seasoned management team with deep industry experience, DMAAU aims to address the increasing demand for domestic drug production amid rising concerns over healthcare affordability and accessibility in the U.S. This strategic approach positions DMAAU as an attractive opportunity for institutional investors looking to engage with transformative healthcare solutions that can shape the future of the industry.
This company is also listed under the following tickers: DMAAR, DMAA.
Website: https://dmaacorp.comSector:
Financial Services
Industry:
Shell Companies
Market Cap
$247M
P/E Ratio
42.00
Free Cash Flow Yield
-0.10%
Beta (5Y)
0.05
Price Chart
Valuation
Market Cap$247M
P/E42.00
Profitability
EBITDA-$539K
EPS$0.26
Financial Health
Debt-to-Equity0%
Free Cash Flow Yield-0.10%
Growth & Risk
Beta (5Y)0.05
Sharpe Ratio0.23